<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03240718</url>
  </required_header>
  <id_info>
    <org_study_id>CE14-122</org_study_id>
    <nct_id>NCT03240718</nct_id>
  </id_info>
  <brief_title>Pilot Study of the Ablative Fractional CO2 Laser in Hypertrophic Scars in Adult Burn Patients</brief_title>
  <official_title>Randomized, Controlled, Within-patient, Single-blinded Pilot Study to Evaluate the Efficacy of the Ablative Fractional CO2 Laser in the Treatment of Hypertrophic Scars in Adult Burn Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, within-patient, single-blinded, pilot study that will
      evaluate the impact of laser treatment on burn HSc relative to self-matched control scars.
      The studied primary outcomes of treatment are scar pliability, thickness, vascularity, pain,
      itch and patient satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior to treatment initiation, two independent scars sites will be selected and an
      anatomically- on each individual. At the selected treatment site the scar will be treated
      with the CORE fractional CO2 laser Participants will receive 3 treatment sessions scheduled 4
      weeks apart. The scar sites will be evaluated at baseline, immediately before the 3rd
      treatment and 12 weeks after their final treatment session.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Characteristics changes</measure>
    <time_frame>baseline, 12 weeks and 24 weeks</time_frame>
    <description>Erythema, elasticity and thickness measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction Questionnaire</measure>
    <time_frame>baseline, 24 weeks</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>Laser treated HSc scar</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Co2 laser treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control scar</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser treatment</intervention_name>
    <description>CORE fractional CO2 laser treatment</description>
    <arm_group_label>Laser treated HSc scar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fitzpatrick skin type &lt;IV (37),

          -  Have sustained a thermal burn injury,

          -  Have at least 2 independent sites that show clinical evidence of HSc,

          -  Are 2 months or more post-injury.

        Exclusion Criteria:

          -  Subjects with skin phototypes IV or higher,

          -  With history of keloidal scarring,

          -  Who have coagulation disorder,

          -  Are taking immunosuppressive medications,

          -  If the mechanism of injury is an electrical, chemical, or cold injury,

          -  Any underlying active skin disease,

          -  Have taken oral Isotreinoin within the last 6 months,

          -  Photosensitivity or have taken photosensitizing medications,

          -  Pregnancy,

          -  Previous treatment with dermabrasion, chemical peel, laser or intense pulsed light
             treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernadette Nedelec, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CRCHUM</affiliation>
  </overall_official>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2017</study_first_submitted>
  <study_first_submitted_qc>August 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2017</study_first_posted>
  <last_update_submitted>August 15, 2017</last_update_submitted>
  <last_update_submitted_qc>August 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cicatrix, Hypertrophic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

